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Abstract
Neurofibromatosis type 1 (NF1, von Recklinghausen’s disease) is one of phacomatoses - genetic disorders triggered by a mutation of a gene. In case of von 
Recklinghausen’s disease the mutation has been recognized as the loss of function mutation of NF1 gene, that results in lack of neurofibromin. The disorder is usually 
diagnosed in early childhood since some of the symptoms are present in infants or even newborns. In some cases however, the symptoms appear in adulthood only 
when they might cause diagnostic problems. We present a study of a 32-year old female patient admitted to Pulmonology Department due to a found round mass in 
her left lung. Further diagnostics revealed other abnormalities and combined with the patient’s physical findings the diagnosis of neurofibromatosis type 1 was made. 
This study presents further medical history of the given patient.
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Introduction
Phacomatoses or neuroectomesodermal dysplasias are developmental 
changes within tissues that occur as a result of a genetic mutation which 
leads to growth and cellular differentiation disorders during the period 
of blastodermic layers and primordia development during the first three 
to four weeks of intrauterine life. Neurofibromatosis type 1, known also 
as von Recklinghausen’s disease, is the most common of phacomatoses, 
occurring in 1 in 2,500 to 4,000 individuals in general population. It 
is inherited as an autosomal dominant trait and causesd by a loss of 
function mutation of the NF1 gene, localized on the long strand of 
chromosome 17 (17q11.2). Both central and peripheral nervous system 
are affected but other organs might be affected as well. Diagnosis is 
usually made in early childhood on the basis of characteristic clinical 
picture. Sometimes though, the disease stays clinically silent until the 
adulthood, when it might become diagnostically challenging.
Case report
In August 2008 a 32-year-old female patient was admitted to 
Pulmonology Clinic at the University Hospital in Kraków due to 
a subpleural mass in the lower lobe of her left lung that had been 
found in a chest X-ray performed because of dyspnea the patient was 
complaining of. This paroxysmal dyspnea had been occurring for 
about five to six years, mostly in the patient’s workplace - a tannery. 
A computed tomography of the patient’s chest performed for further 
diagnostics revealed a similar mass in the right lung aside from the 
previously known one in the left lung. Both of the masses were localized 
in close adherence to the chest walls and the potential sources of the 
tumours’ origin were established to be intercostal nerves. Furthermore 
on physical examination multiple skin discolorations of cafe-au-lait 
sort and tuberous masses on the back - below the left scapula and over 
the left breast were found and brought to a physician’ attention.
The patient stated that in the past she had undergone a surgical 
excision of skin lesions twice - in 1995 from the left orbital cavity and 
in 1997 from her left hand. Histopathological picture of the lesions 
was corresponding to neurofibroma. Besides that the patient had been 
remaining under neurological treatment due to epilepsy diagnosed 
in 2001. Electroencephalogram (EEG) revealed then a tendency to 
paroxysmal discharges. The patient was a non-smoker, consumed 
alcohol occasionally - a few times a year. Her family history in regard 
to cancer was positive. Both her father and her mother’s brother had 
died from gastric cancer.
Given the full clinical picture, a preliminary diagnosis of von 
Recklinghausen’s disease was made. Moreover, ophthalmological 
examination revealed Lisch nodules in both irises. The diagnosis was 
confirmed by a consultation at genetic outpatient’s clinic at Children’s 
University Hospital in Kraków. The patient was referred to surgical 
ward in order to remove the oval-shaped subcutaneous tumour in her 
left supraclavicular fossa. The histopatological picture of the tumour 
was again corresponding to neurofibroma. The tumours in the patient’s 
chest were diagnosed as neurofibromas without further invasive testing 
due to high probability of that background. Besides that a diagnosis 
of asthma was made. Because paroxysmal dyspnea occurred only 
during the patient’s work in the tannery the background of asthma 
was established as occupational having disqualified the patient from 
hypersensitivity test due to coexisting epilepsy which is a contradiction 
to consecutive spirometry tests. Asthma was treated with good results. 
In 2010 the patient stopped her work in the tannery and her symptoms 
subsided completely.
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In 2009 the mass below the patient’s left scapula started to grow. 
It was then about 6 centimeters in diameter. The patient complained 
of pain in her left hand. Computed tomography of the chest was 
performed. The patient was qualified to surgical removal of the mass. 
Besides that the patient reported periodic neck oedema, most probably 
connected to a newly revealed in computed tomography mass (22 
millimeters in diameter) located in superior mediastinum between 
subclavian vein and brachiocephalic trunk. Moreover the computed 
tomography revealed three smooth contoured focal lesions within 
intercostal spaces: 26 x 33mm at the level of left 9th lung segment, 20 x 
11mm at the level of right 2nd lung segment and 11 x 6mm at the level 
of apex of the right lung.
In October 2010 the mass below the patient’s left scapula (about 
11 centimeters in diameter then) was removed and the material was 
forwarded to histopathological examination that revealed malignant 
peripheral nerve sheath tumour.  After the surgery PET scan was 
performed that revealed several areas of elevated uptake of the tracer 
within:
• soft tissues of the back around the left scapula area - corresponding 
to a postoperative scar;
• a chest wall adjacent nodule of right 2nd lung segment of the size of 
25 x 12mm;
• a chest wall adjacent tumour of 9th left lung segment of the size of 
33 x 23mm;
• para aortic lymph nodes of the size of 25 x 33mm in the area of 
aortic bifurcation;
• a focal lesion of the size of 16 x 14mm within subcutaneous tissue 
around left iliac crest; 
• left internal iliac lymph nodes of the size of 40 x 41mm;
• a tumour within left gluteal area of the size of 64 x 77mm;
• a tumour of the back side of left femur below proximal extremity of 
the size of 53 x 50mm;
• a tumour within one third proximal of anteromedial part of right 
femur of the size of 48 x 53mm.
The findings were stated as correspondent to neurofibromatosis 
type 1.
The patient was referred for further treatment to Oncology Ward 
at University Hospital in Kraków. Three cycles of chemotherapy 
(adriamycin in monotherapy) were given from November of 25th, 2010 
to January of 20th, 2011.
In 2011 a relapse of the left scapula tumour occurred. It was 
surgically removed in April 2011 and identical histopathological picture 
was confirmed. After the surgery the same schedule of chemotherapy 
(3 cycles with adriamycin) was administered. Regardless of the 
treatment a progression of the mass was observed. Radiotherapy of the 
left scapula area was administered in July 2011. Then another mass in 
the area of neck was observed.  PET scan in September 2011 revealed 
disseminations of sarcoma. Six cycles of ifosfamide were administered 
from October 7th, 2011 to February 27th, 2011 at the Department of 
Oncology at University Hospital in Kraków. After the treatment PET 
scan in March 2012 did not show any progression of the disease.
The patient was admitted to Outpatient Ambulatory of Department 
of Oncology at University Hospital for the last time on April 10th, 2012. 
Her last appointment at Pulmonology Outpatient Clinic at University 
Hospital in Kraków took place in May 2012. The patient appeared 
then significantly changed with masklike face. She complained of 
progressive weakness, drowsiness, dyspnea for most of the days. Some 
time later the patient’s mother reported the patient’s death.
Discussion
The neurofibromatoses are a group of three different, genetically 
determined diseases that cause the growth of tumours in the 
nervous system. Tumours grow in neuroglial cells and myelin 
sheats. Neurofibromas develop usually in neurofibromatosis type 
1 (von Recklinghausen’s disease), while in neurofibromatosis type 
2 and schwanomatosis the most often observed type of tumours are 
schwannomas. Most of the tumours are benign but sometimes they 
might become malignant. Neorofibromatosis type 1 occur in both 
sexes and in people of every race and ethnical groups. The diagnosis is 
most often made in early childhood - almost often by the time a child 
is 10 years old - as the symptoms are often evident at birth or shortly 
afterwards. The presented case illustrates an example of the disease’s 
manifest in adulthood.
Many patients inherit the disease, while 30-50% of new cases are 
caused by a spontaneous mutation in NF1 gene. When the mutation 
appears, it might be passed to next generations.  
Characteristic features of neurofibromatosis type 1 clinical picture are:
• cafe-au-lait spots that usually appear in the first few months of life 
but might be present in newborns;
• freckling in the area of the armpits or the groins, usually appearing 
during adolescence;
• subcutaneous nodules - neurinomas or neurofibromas, that appear 
usually around the age of 10.  Neurofibromas might transform to 
neurofibrosarcomas or malignant peripheral nerve sheath tumours;
• plexiform neurofibromas appearing at every age;
• Lisch nodules - hamartoma type growths on the iris of the eye, 
found in about 90% of patients above 6   years old;
• bone deformations, pseudoarthroses;
• optic nerve’s glioblastomas;
• epilepsy - in 10-15% of children suffering from NF1;
• mental retardation in 20% of patients;
• a common problem is hyperactivity, dyslexia and learning 
disabilities.
A diagnosis is made in a patient that meets 2 or more of the 
following criteria:
• five or more cafe-au-lait spots measuring at least 5 millimeters 
before adolescence or six or more cafe-au-lait stains measuring at 
least 15 millimeters after the aolescence;
• freckling in the area of the armpits or the groins;
• optic nerve’s glioblastoma;
• at least two neurofibromas or one plexiform neurofibroma;
• sphenoid bone dysplasia;
• pseudoarthroses;
• cortical bone deformation;
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• two or more Lisch nodules;
• at least one relative with NF1.
Life expectancy in these patients is about 10 years shorter than 
in general population [1]. Neurofibromatosis type 1 is a progressive 
disease and, although in some patients the symptoms remain stable, in 
majority of the patients with the passing time the symptoms escalate. 
It is impossible to predict the direction of the disease’s progression 
in an individual patient. Neurofibromatosis type 1 increases the risk 
of cancerous transformation, especially nervous system tumours. 
Furthermore interstitial lung diseases, lung cancer, pulmonary 
hypertension and gastrointestinal tract neoplasms might occur - 
usually in the adulthood [2,3].
Although in general respiratory symptoms are rare in this 
disease, there are a lot of reports of pulmonary complications of von 
Reclinghausen’s disease. This is the reason why their natural course 
have not been fully recognized yet, although they might be severe and 
life-threatening [4,5].
In the illustrated case the mass that primarily seemed to be a lung 
tumour, turned out to be adjacent to the chest wall and its exact location 
and the place of origin (intercostal nerve) was established after having 
chest computed tomography performed. This is how other masses 
within the chest were revealed as long as costal osteolysis - caused by 
the biggest of tumours, that corresponds to dural ectasis. [6].
In the presented patient a transformation from neurofibroma 
to malignant peripheral nerve sheath tumour (MPNST) occurred. 
Malignant peripheral nerve sheath tumours (MPNST) are aggressive 
soft tissues sarcomas that take their origin in neural cells. They are 
characterized by rapid disease progression, high mortality rate, high 
relapse rate and low response rates to cytotoxic chemotherapy. They 
remain amongst the most challenging mesenchymal malignancies 
to treat. In 50% of cases their occurrence is associated with von 
Reclinghausen’s disease. The prognosis then is poorer than in cases of 
their spontaneous appearance. In literature reports of higher survival 
rate in patients with MPNST treated with radiochemotherapy are 
noticed, which is the treatment administered to the presented patient [7].
In view of wide range of pathological changes arising in the context 
to neurofibromatosis type 1, further study of individual cases in order 
to its natural course recognition and treatment methods evaluation is 
essential.
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